Carderock Capital Management Inc Abbott Laboratories Transaction History

Carderock Capital Management Inc

$408 Million
Q3 2024

A detailed history of Carderock Capital Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Carderock Capital Management Inc holds 5,335 shares of ABT stock, worth $628,249. This represents 0.15% of its overall portfolio holdings.

Number of Shares

5,335

Previous 5,385 0.93%

Holding current value

$628,249

Previous $559,000 8.77%

% of portfolio

0.15%

Previous 0.15%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	SELL	$100.07 - $118.13 $5,003 - $5,906	-50 Reduced 0.93%	5,335 $608,000
Q2 2024 Jul 22, 2024	SELL	$100.73 - $112.44 $2.7 Million - $3.01 Million	-26,782 Reduced 83.26%	5,385 $559,000
Q1 2024 Apr 23, 2024	SELL	$109.52 - $120.96 $1.83 Million - $2.02 Million	-16,675 Reduced 34.14%	32,167 $3.66 Million
Q4 2023 Jan 23, 2024	BUY	$90.19 - $110.4 $17,045 - $20,865	189 Added 0.39%	48,842 $5.38 Million
Q3 2023 Oct 23, 2023	SELL	$95.53 - $114.62 $67,826 - $81,380	-710 Reduced 1.44%	48,653 $4.71 Million
Q2 2023 Jul 25, 2023	BUY	$100.78 - $112.29 $7,155 - $7,972	71 Added 0.14%	49,363 $5.38 Million
Q1 2023 Apr 19, 2023	SELL	$96.86 - $114.01 $198,175 - $233,264	-2,046 Reduced 3.99%	49,292 $4.99 Million
Q4 2022 Jan 20, 2023	SELL	$95.06 - $111.52 $47,054 - $55,202	-495 Reduced 0.95%	51,338 $5.64 Million
Q3 2022 Nov 04, 2022	SELL	$96.76 - $112.03 $1.31 Million - $1.52 Million	-13,538 Reduced 20.71%	51,833 $5.02 Million
Q2 2022 Jul 21, 2022	BUY	$102.07 - $123.37 $117,788 - $142,368	1,154 Added 1.8%	65,371 $7.1 Million
Q1 2022 Apr 28, 2022	SELL	$114.02 - $139.04 $155,979 - $190,206	-1,368 Reduced 2.09%	64,217 $7.6 Million
Q4 2021 Jan 31, 2022	BUY	$115.53 - $141.46 $600,178 - $734,884	5,195 Added 8.6%	65,585 $9.23 Million
Q3 2021 Oct 29, 2021	BUY	$116.66 - $129.06 $49,347 - $54,592	423 Added 0.71%	60,390 $7.13 Million
Q2 2021 Jul 30, 2021	BUY	$105.79 - $124.53 $115,311 - $135,737	1,090 Added 1.85%	59,967 $6.95 Million
Q1 2021 May 07, 2021	SELL	$108.84 - $128.23 $78,582 - $92,582	-722 Reduced 1.21%	58,877 $7.06 Million
Q4 2020 Feb 05, 2021	BUY	$105.0 - $114.42 $38,010 - $41,420	362 Added 0.61%	59,599 $6.53 Million
Q3 2020 Oct 27, 2020	BUY	$91.64 - $111.29 $28,133 - $34,166	307 Added 0.52%	59,237 $6.45 Million
Q2 2020 Aug 04, 2020	BUY	$76.57 - $98.0 $63,246 - $80,948	826 Added 1.42%	58,930 $5.39 Million
Q1 2020 May 11, 2020	SELL	$62.82 - $91.86 $53,334 - $77,989	-849 Reduced 1.44%	58,104 $4.59 Million
Q4 2019 Feb 04, 2020	BUY	$78.51 - $87.4 $70,109 - $78,048	893 Added 1.54%	58,953 $5.12 Million
Q3 2019 Oct 24, 2019	BUY	$81.84 - $88.74 $173,500 - $188,128	2,120 Added 3.79%	58,060 $4.86 Million
Q2 2019 Jul 15, 2019	BUY	$72.88 - $85.0 $2.2 Million - $2.56 Million	30,140 Added 116.82%	55,940 $4.71 Million
Q1 2019 Apr 23, 2019	BUY	$66.22 - $80.06 $853,575 - $1.03 Million	12,890 Added 99.85%	25,800 $2.06 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $30,157 - $34,164	460 Added 3.69%	12,910 $934,000
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $65,370 - $78,862	1,075 Added 9.45%	12,450 $913,000
Q2 2018 Jul 16, 2018	BUY	$57.57 - $63.54 $60,448 - $66,717	1,050 Added 10.17%	11,375 $694,000
Q1 2018 Apr 27, 2018	BUY	$56.27 - $63.62 $80,578 - $91,103	1,432 Added 16.1%	10,325 $619,000
Q4 2017 Jan 25, 2018	BUY	$53.68 - $57.47 $34,516 - $36,953	643 Added 7.79%	8,893 $508,000
Q3 2017 Nov 15, 2017	SELL	$48.06 - $53.64 $70,888 - $79,119	-1,475 Reduced 15.17%	8,250 $440,000
Q2 2017 Aug 10, 2017	BUY	N/A	9,725	9,725 $473,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Carderock Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Carderock Capital Management Inc with notifications on news.

Account

Carderock Capital Management Inc Abbott Laboratories Transaction History